Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations

G. Brunetti; I. Jedrychowska; A. Bossi; M. Fiori; P. Pisati; M. Guglielminetti

Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations

G. Brunetti, I. Jedrychowska, A. Bossi, M. Fiori, P. Pisati, M. Guglielminetti

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Article › peer-review

Abstract

A case report of Allergic Bronchopulmonary Aspergillosis (ABPA) is described. The authors emphasize: 1) the suitability, in diagnostic phase, of high resolution computed tomography for the detection of central bronchiectasis and the usefulness of Eosinophil Cationic Protein (ECP) in monitoring the activity of disease. 2) The efficacy and the good tolerance of itraconazole (200 mg/day) as adjunctive therapy in association with steroids. Interestingly a transient remission of radiological abnormalities, pulmonary function tests, blood and alveolar hypereosinophilia as well as a reduction of IgE serum concentration, was obtained after a first period of therapy with itraconazole alone.

Original language	English
Pages (from-to)	203-206
Number of pages	4
Journal	Journal de Mycologie Medicale
Volume	7
Issue number	4
Publication status	Published - 1997

Keywords

Allergic bronchopulmonary aspergillosis (ABPA)
Itraconazole

ASJC Scopus subject areas

Agricultural and Biological Sciences (miscellaneous)
Microbiology

Fingerprint Dive into the research topics of 'Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations'. Together they form a unique fingerprint.

Cite this

@article{575d9eab617d4adf81b4e7c4cf2f90d2,

title = "Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations",

abstract = "A case report of Allergic Bronchopulmonary Aspergillosis (ABPA) is described. The authors emphasize: 1) the suitability, in diagnostic phase, of high resolution computed tomography for the detection of central bronchiectasis and the usefulness of Eosinophil Cationic Protein (ECP) in monitoring the activity of disease. 2) The efficacy and the good tolerance of itraconazole (200 mg/day) as adjunctive therapy in association with steroids. Interestingly a transient remission of radiological abnormalities, pulmonary function tests, blood and alveolar hypereosinophilia as well as a reduction of IgE serum concentration, was obtained after a first period of therapy with itraconazole alone.",

keywords = "Allergic bronchopulmonary aspergillosis (ABPA), Itraconazole",

author = "G. Brunetti and I. Jedrychowska and A. Bossi and M. Fiori and P. Pisati and M. Guglielminetti",

year = "1997",

language = "English",

volume = "7",

pages = "203--206",

journal = "Journal de Mycologie Medicale",

issn = "1156-5233",

publisher = "Elsevier Masson",

number = "4",

}

TY - JOUR

T1 - Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations

AU - Brunetti, G.

AU - Jedrychowska, I.

AU - Bossi, A.

AU - Fiori, M.

AU - Pisati, P.

AU - Guglielminetti, M.

PY - 1997

Y1 - 1997

N2 - A case report of Allergic Bronchopulmonary Aspergillosis (ABPA) is described. The authors emphasize: 1) the suitability, in diagnostic phase, of high resolution computed tomography for the detection of central bronchiectasis and the usefulness of Eosinophil Cationic Protein (ECP) in monitoring the activity of disease. 2) The efficacy and the good tolerance of itraconazole (200 mg/day) as adjunctive therapy in association with steroids. Interestingly a transient remission of radiological abnormalities, pulmonary function tests, blood and alveolar hypereosinophilia as well as a reduction of IgE serum concentration, was obtained after a first period of therapy with itraconazole alone.

AB - A case report of Allergic Bronchopulmonary Aspergillosis (ABPA) is described. The authors emphasize: 1) the suitability, in diagnostic phase, of high resolution computed tomography for the detection of central bronchiectasis and the usefulness of Eosinophil Cationic Protein (ECP) in monitoring the activity of disease. 2) The efficacy and the good tolerance of itraconazole (200 mg/day) as adjunctive therapy in association with steroids. Interestingly a transient remission of radiological abnormalities, pulmonary function tests, blood and alveolar hypereosinophilia as well as a reduction of IgE serum concentration, was obtained after a first period of therapy with itraconazole alone.

KW - Allergic bronchopulmonary aspergillosis (ABPA)

KW - Itraconazole

UR - http://www.scopus.com/inward/record.url?scp=0031425334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031425334&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031425334

VL - 7

SP - 203

EP - 206

JO - Journal de Mycologie Medicale

JF - Journal de Mycologie Medicale

SN - 1156-5233

IS - 4

ER -

Eosinophil lung related to allergic bronchopulmonary aspergillosis. Diagnostic and therapeutic considerations

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this